Anthropology

Do psychotropic[s] enhance, or diminish, human agency?

*then— a landscape in ancient Britain …[plants] are reliable and effective because they implement the findings of neuroscience and supplement… our humanist discourse about self-development and agency. In using… we become transhuman hybrid beings who build tools into the regulatory plant of the body. One question to ask then is: How many individuals have found,…

READ MORE
Biography/Memoir

Opium production breaks records again

Within just one year, the area used to cultivate poppies in Afghanistan has increased to 420,000 hectares from 328,000 in just one year.  This, along with improved opium yields, has increased global opium production by 65 percent in 2017. 10,500 tonnes of opium were produced in 2017 — the highest since the UNODC first began…

READ MORE
Politics

Guy behind OxyContin [another patent?]

“Sackler Crossing” at British Royal Botanic Gardens at Kew (The Sacklers, known mostly for philanthropy before the opioid epidemic, deny fueling a crisis that killed 42,000 people in 2016.)   A billionaire [Richard Sackler] accused of worsening the opioid crisis just won a patent for a drug to treat opioid addiction. “It’s reprehensible what Purdue Pharma has…

READ MORE
Politics

Oregon sues oxycontin maker, saying it minimized risks

Spokesman Bob Josephson said the [State of Oregon] was inappropriately substituting its judgment for the judgment of experts at U.S. Food and Drug Administration.​  Attorney General Ellen Rosenblum charged that Purdue has engaged in racketeering and misleading activity over the last decade. A spokesman at Purdue Pharma, Robert Josephson (who describes himself on LinkedIN as “deep and rich…

READ MORE
Modern Culture

A new front opens up: psychoactive mushroom decriminalization in Denver

It’s a new front in the crucial struggle to roll back the horror that is psychedelic prohibition.  There are now two fronts open. First, there is the laborious, time-intensive and money-intensive pathway to obtaining the federal government’s approval of psychedelic substances for marketing in interstate commerce (i.e. demonstrating to the satisfaction of the FDA that…

READ MORE
Biography/Memoir

[FDA] Health official signals support for marijuana decriminalization

FDA Commissioner Scott Gottlieb started the interview by explaining that the FDA has approved synthetic versions of cannabinoids and pharmaceutical-grade derivatives of marijuana—and arguing that those products are preferable to using botanical cannabis for medical purposes. When the conversation turned to federal marijuana laws, Gottlieb drew a stark contrast between legalization and decriminalization… “Well, you know, there’s…

READ MORE